Group 1 - The core viewpoint of the articles highlights Samsung Medical's stock performance, with a closing price of 24.4 yuan, an increase of 4.18%, and a rolling PE ratio of 14.38, marking a new low in 60 days [1] - The total market capitalization of Samsung Medical is reported at 34.288 billion yuan, with a comparison to the industry average PE ratio of 38.76 and a median of 41.39, placing the company at the 35th position in the industry ranking [1][2] - As of March 31, 2025, the number of shareholders for Samsung Medical is 16,366, a decrease of 898 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Samsung Medical's main business segments include smart power distribution and medical services, with key products such as smart meters, high-end gateway meters, and various energy solutions [1] - The company has received multiple accolades, including recognition as a national-level intellectual property demonstration enterprise and a provincial key enterprise research institute [1] - For Q1 2025, Samsung Medical reported a revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33%, with a sales gross margin of 28.90% [2]

Core Viewpoint - Samsung Medical's stock price increased by 4.56% to 23.61 yuan, with a rolling PE ratio of 13.91, marking a new low in 55 days, and a total market capitalization of 33.178 billion yuan [1][2] Company Summary - Samsung Medical's main business segments include smart power distribution and medical services, with key products such as smart meters, high-end gateway meters, smart terminals, power boxes, communication modules, and various integrated solutions [1] - The company has received multiple accolades, including being recognized as a national-level intellectual property demonstration enterprise and a provincial key enterprise research institute [1] Financial Performance - For the first quarter of 2025, Samsung Medical reported revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33% [2] - The company's gross profit margin stands at 28.90% [2] Industry Comparison - In the electric grid equipment industry, Samsung Medical's PE ratio of 13.91 is significantly lower than the industry average of 38.47 and the median of 41.87 [2] - The company ranks 34th in terms of PE ratio within its industry [1]

7月31日，三星医疗今日收盘22.49元，上涨4.31%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到13.25倍，创13天以来新低，总市值316.04亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入36.31亿元，同比20.03%；净利润4.89亿元，同 比34.33%，销售毛利率28.90%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)5三星医疗13.2513.992.51316.04亿行业平均 36.1540.353.6793.67亿行业中值39.6442.402.7448.10亿1炬华科技11.1212.171.9680.88亿2新联电子 12.3018.011.4048.04亿3正泰电器12.3612.621.13488.89亿4金杯电工12.5212.971.8073.76亿6海兴电力 13.9912.981.79130.03亿7友讯达15.2113.582.5626.92亿8柘中股份17.1285.302.1862.39亿9长高电新 17.7718.041.8545.47亿10宏力达18.0416.780.9837.38亿11明阳电气18.1318.742 ...

Core Viewpoint - Samsung Medical's stock closed at 21.82 yuan, down 1.31%, with a rolling PE ratio of 12.91 times, significantly lower than the industry average of 38.92 times [1][2] Company Overview - Samsung Medical's main business segments include smart power distribution and medical services, with key products such as smart meters, high-end gateway meters, and various energy solutions [1] - The company has received multiple accolades, including being recognized as a national-level intellectual property demonstration enterprise and a provincial key enterprise research institute [1] Financial Performance - For Q1 2025, Samsung Medical reported revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, up 34.33% [2] - The company's gross profit margin stands at 28.90% [2] Shareholder Information - As of March 31, 2025, Samsung Medical had 16,366 shareholders, a decrease of 898 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]

Group 1 - The core viewpoint of the articles highlights Samsung Medical's current market performance, including a closing price of 21.5 yuan, a decline of 2.93%, and a rolling PE ratio of 12.72 times, with a total market capitalization of 30.337 billion yuan [1][2] - The average PE ratio for the electric grid equipment industry is 37.78 times, with a median of 39.13 times, positioning Samsung Medical at the 35th rank within the industry [1][2] - As of the first quarter of 2025, 14 institutions hold shares in Samsung Medical, with a total of 42.8023 million shares valued at 960 million yuan [1] Group 2 - For the first quarter of 2025, Samsung Medical reported an operating income of 3.631 billion yuan, representing a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33%, with a sales gross margin of 28.90% [2] - The company's PE (TTM) is 12.72, while the industry average is 37.78, indicating a significant undervaluation compared to peers [2] - Samsung Medical's main business segments include smart power distribution, medical services, and various products such as smart meters, high-end gateway meters, and energy storage systems [1]

从行业市盈率排名来看，公司所处的电网设备行业市盈率平均34.69倍，行业中值36.31倍，三星医疗排 名第35位。 股东方面，截至2025年3月31日，三星医疗股东户数16366户，较上次减少898户，户均持股市值35.28万 元，户均持股数量2.76万股。 宁波三星医疗电气股份有限公司的主营业务是智能配用电板块、医疗服务板块。公司的主要产品是智能 电表、高端关口表、智能终端、电力箱、通信模块、AMI/MDM等系统集成解决方案和总包服务、变压 器、环网柜/环保气体柜、一二次融合成套设备、高低压开关成套设备、智能化预装式变电站、光伏箱 变、风电箱变、光伏预制舱、逆变器、充电桩、储能产品及系统、医疗服务。公司荣获国家级知识产权 示范企业、省重点企业研究院、省企业技术中心，下属子公司三星智能荣获国家级知识产权优势企业、 省高新技术企业研究开发中心。报告期内，公司及下属子公司分别荣获国家绿色供应链。 最新一期业绩显示，2025年一季报，公司实现营业收入36.31亿元，同比20.03%；净利润4.89亿元，同 比34.33%，销售毛利率28.90%。 6月3日，三星医疗今日收盘21.62元，下跌1.73%，滚动市盈率P ...